Description
Investigating the RNA-binding protein HuD and CARM1 as novel therapeutic targets for Spinal Muscular Atrophy
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02018-10-01$937,126
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2018-10-01(start date) | $937,126 | — | Investigating the RNA-binding protein HuD and CARM1 as novel therapeutic targets for Spinal Muscular Atrophy |
Related records · 3
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2024-2025-Q1-01320 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $15,000 | FY2025 |
| 110_2020_2021_Q2_2563 | Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada · Discovery Research | $4,160 | FY2021 |
| 236-2019-2020-Q1-00981 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $925,650 | FY2020 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2018-2019-Q3-00237 · retrieved 2026-11-15.